CRKT yields 5714.29% · JNJ yields 2.13%● Live data
📍 CRKT pulled ahead of the other in Year 1
Combined, CRKT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CRKT + JNJ for your $10,000?
Cirmaker Technology Corporation engages in the manufacture, distribution, and assembling of various electronic parts and components for sale primarily in the Asian markets. It provides electronic terminals, electronic blocks and accessories, electronic panel control and locking components, power distribution blocks and accessories, electronic timer and relay sockets, optical fiber connectors and adapters, car audio components, DVD players, electronics, cooling fins and systems for laptop and personal computers, and electrical tools, and other devices. The company also manufactures LCD backlight components and produces voice over Internet Protocol telephones. Further, it distributes or resells crimping tools, switches, cable ties, meters, sirens, power cords, and terminal strips, as well as imports and exports computer chips and various electronic products. Cirmaker Technology Corporation sells its products through sales personnel and marketing agents. The company was organized in 1984 and is based in Taoyuan, Taiwan.
Full CRKT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.